Proposed Data Collections Submitted for Public Comment and Recommendations, 33464-33465 [2012-13689]
Download as PDF
<![CDATA[
33464
Federal Register / Vol. 77, No. 109 / Wednesday, June 6, 2012 / Notices
TABLE 1—ANNUALIZED BURDEN HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form
1. Individuals in households ..............
2. Individuals in households ..............
NHANES Questionnaire ....................
Special Studies ..................................
3,850
1,000
1
1
2.4
3
9,240
3,000
Total ............................................
............................................................
........................
........................
......................
12,240
Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–13686 Filed 6–5–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–12–0824]
mstockstill on DSK4VPTVN1PROD with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
VerDate Mar<15>2010
17:24 Jun 05, 2012
Jkt 226001
Proposed Project
BioSense 2.0 (OMB No. 0920–0824,
exp. 10/31/2012)—Revision—Office of
Surveillance, Epidemiology, and
Laboratory Services (OSELS), Public
Health Surveillance and Informatics
Program Office (PHSIPO) {Proposed}
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description:
The BioSense Program was created by
congressional mandate as part of the
Public Health Security and Bioterrorism
Preparedness and Response Act of 2002,
and it was launched by the Centers for
Disease Control and Prevention (CDC) in
2003. BioSense is a near real-time
surveillance system that receives and
processes electronic healthcare
encounter data, including, chief
complaints, final diagnosis codes,
procedure codes, clinical laboratory,
pharmacy prescription, and patient
demographic data from participating
public health jurisdictions’ non-federal
hospital emergency departments and
inpatient facilities in addition to all
United States Department of Defense
(DoD) and Veterans Affairs (VA)
outpatient hospitals and clinics
nationwide. The BioSense Program also
receives pharmacy data from a private
sector health information exchange firm
and laboratory data from two nationallevel private sector clinical laboratories.
The BioSense Program is in the
process of transitioning from the
original BioSense application to the
BioSense 2.0 application that has new
governance, a new organizational
structure, and a new process for data
submission and management. The
Association of State and Territorial
Health Officials (ASTHO) has been
funded through a cooperative agreement
with CDC’s Division of Notifiable
Disease and Healthcare Information
(DNDHI) within the Public Health
Surveillance and Informatics Program
Office (PHSIPO) of the Office of
Surveillance, Epidemiology, and
Laboratory Services (OSELS) to facilitate
the governance of BioSense 2.0, and
through a contract with a vendor,
ASTHO will offer access and use of
BioSense 2.0 on a voluntary basis to
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
state, local, and territorial health
jurisdictions.
Unlike the original BioSense
application where participating
organizations’ data were processed and
stored at CDC in the CDC owned and
operated Information Technology
Services Office’s Mid-Tier Data Center
on secure servers, all data submitted by
users in BioSense 2.0 will reside in a
cloud-enabled, web-based platform that
sits in the secure, private Government
Cloud and is in compliance with the
Federal Information Security
Management Act. The platform will
provide users with an exclusive secure
space as well as tools for posting,
receiving, controlling, analyzing, and
sharing their public health surveillance
information with other public health
jurisdictions, CDC, or other public
health partners. The public health
jurisdiction will retain ownership of any
data it contributes to its exclusive
secure space within BioSense 2.0.
The BioSense 2.0 cloud also provides
the CDC’s BioSense Program its own
exclusive secure space to receive, store,
and analyze data. CDC has agreements
with VA, DoD, two national-level
private sector clinical laboratories, and
a private sector health information
exchange firm to provide healthcare
encounter data to CDC’s secure space for
the purpose of national public health
situation awareness and syndromic
surveillance. These organizations
automatically chose to share with CDC
when they were recruited to submit data
to the BioSense 2.0 cloud environment.
Because they are not required to choose
sharing permissions, collecting already
existing healthcare encounter data
submitted via electronic record
transmission from them entails no
burden hours.
In addition to providing a secure,
exclusive space for use by CDC and
secure, exclusive spaces for use by each
participating state, local, and territorial
public health jurisdiction, BioSense 2.0
provides a second secure space in the
cloud for public health jurisdictions to
share aggregate data with other
participating jurisdictions and CDC.
Whenever possible, the BioSense
E:\FR\FM\06JNN1.SGM
06JNN1
33465
Federal Register / Vol. 77, No. 109 / Wednesday, June 6, 2012 / Notices
shared space for public health practice
and surveillance purposes.
In order to continue meeting the
congressional mandate in the BioSense
2.0 application, the BioSense Program
maintains 3 different types of
information collection: (1) Contact
information (name, telephone number,
email address, and street address)
needed for recruitment of up to 20
participating public health jurisdictions
to BioSense 2.0 per year; (2) one-time
collection of information (name, email
address, title, organizational affiliation,
security questions, and password) to
provide access to the BioSense 2.0 cloud
and its tools for all appropriate users in
participating jurisdictions and
organizations, and (3) collection of
Program plans to share aggregate-level
pharmacy and laboratory data with
public health jurisdictions. To
participate in the shared space,
jurisdiction administrators must simply
select from drop-down lists to choose
their sharing permissions on the
BioSense 2.0 application, and they will
have the right at any time to revise the
level of sharing permissions regarding
the data in their secure space.
As part of access to the shared space,
public health jurisdictions will be
required to grant CDC access to, at
minimum, aggregate level data (city,
county, or state) from their jurisdiction
that has been placed in the shared
space. They must also agree that CDC
may review data contributed to the
already existing healthcare encounter
data submitted to the cloud via
electronic record transmission from
participating public health jurisdictions’
non-federal hospitals, VA, DoD, two
national-level private sector clinical
laboratories, and a private sector health
information exchange firm. Though a
large number of electronic records are
transmitted from each entity each year,
once the automated interfaces are set up
for transmission (choosing sharing
permissions), there is no human burden
for record transmission.
This request is for a 3-year approval.
There are no costs to survey
respondents other than their time to
participate.
ESTIMATES OF ANNUALIZED BURDEN HOURS
Number of
responses
per
respondent
Number of
respondents
Type of respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Recruitment
State, Local, and Territorial Public Health Jurisdictions ..................................
Federal Government ........................................................................................
Private Sector (national clinical laboratory corporations, and a private sector
health information exchange company) .......................................................
20
2
1
1
1
1
20
2
3
1
1
3
200
30
50
1
1
1
5/60
5/60
5/60
17
3
4
Access to BioSense 2.0 Application
State, Local, and Territorial Public Health Jurisdictions ..................................
Federal Government ........................................................................................
Private Sector ..................................................................................................
Data Collection: Administrator Sharing Permissions
State, Local, and Territorial Public Health Jurisdictions ..................................
Federal Government ........................................................................................
Private Sector (national clinical laboratory corporations, and a private sector
health information exchange company) .......................................................
20
2
1
0
5/60
0
2
0
3
0
0
0
Total ..........................................................................................................
........................
........................
........................
51
Kimberly S. Lane,
Deputy Director, Office of Science Integrity,
Office of the Associate Director for Science,
Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012–13689 Filed 6–5–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
[60Day–12–0822]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
VerDate Mar<15>2010
17:24 Jun 05, 2012
Jkt 226001
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 and
send comments to Kimberly S. Lane,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an email to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Intimate Partner and Sexual
Violence Surveillance System (OMB No.
0920–0822, exp. 09/30/2012)—
Revision—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
E:\FR\FM\06JNN1.SGM
06JNN1
]]>Agencies
[Federal Register Volume 77, Number 109 (Wednesday, June 6, 2012)]
[Notices]
[Pages 33464-33465]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-13689]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-12-0824]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to Kimberly S. Lane, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an email to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
BioSense 2.0 (OMB No. 0920-0824, exp. 10/31/2012)--Revision--Office
of Surveillance, Epidemiology, and Laboratory Services (OSELS), Public
Health Surveillance and Informatics Program Office (PHSIPO)
{Proposed{time} Centers for Disease Control and Prevention (CDC).
Background and Brief Description: The BioSense Program was created
by congressional mandate as part of the Public Health Security and
Bioterrorism Preparedness and Response Act of 2002, and it was launched
by the Centers for Disease Control and Prevention (CDC) in 2003.
BioSense is a near real-time surveillance system that receives and
processes electronic healthcare encounter data, including, chief
complaints, final diagnosis codes, procedure codes, clinical
laboratory, pharmacy prescription, and patient demographic data from
participating public health jurisdictions' non-federal hospital
emergency departments and inpatient facilities in addition to all
United States Department of Defense (DoD) and Veterans Affairs (VA)
outpatient hospitals and clinics nationwide. The BioSense Program also
receives pharmacy data from a private sector health information
exchange firm and laboratory data from two national-level private
sector clinical laboratories.
The BioSense Program is in the process of transitioning from the
original BioSense application to the BioSense 2.0 application that has
new governance, a new organizational structure, and a new process for
data submission and management. The Association of State and
Territorial Health Officials (ASTHO) has been funded through a
cooperative agreement with CDC's Division of Notifiable Disease and
Healthcare Information (DNDHI) within the Public Health Surveillance
and Informatics Program Office (PHSIPO) of the Office of Surveillance,
Epidemiology, and Laboratory Services (OSELS) to facilitate the
governance of BioSense 2.0, and through a contract with a vendor, ASTHO
will offer access and use of BioSense 2.0 on a voluntary basis to
state, local, and territorial health jurisdictions.
Unlike the original BioSense application where participating
organizations' data were processed and stored at CDC in the CDC owned
and operated Information Technology Services Office's Mid-Tier Data
Center on secure servers, all data submitted by users in BioSense 2.0
will reside in a cloud-enabled, web-based platform that sits in the
secure, private Government Cloud and is in compliance with the Federal
Information Security Management Act. The platform will provide users
with an exclusive secure space as well as tools for posting, receiving,
controlling, analyzing, and sharing their public health surveillance
information with other public health jurisdictions, CDC, or other
public health partners. The public health jurisdiction will retain
ownership of any data it contributes to its exclusive secure space
within BioSense 2.0.
The BioSense 2.0 cloud also provides the CDC's BioSense Program its
own exclusive secure space to receive, store, and analyze data. CDC has
agreements with VA, DoD, two national-level private sector clinical
laboratories, and a private sector health information exchange firm to
provide healthcare encounter data to CDC's secure space for the purpose
of national public health situation awareness and syndromic
surveillance. These organizations automatically chose to share with CDC
when they were recruited to submit data to the BioSense 2.0 cloud
environment. Because they are not required to choose sharing
permissions, collecting already existing healthcare encounter data
submitted via electronic record transmission from them entails no
burden hours.
In addition to providing a secure, exclusive space for use by CDC
and secure, exclusive spaces for use by each participating state,
local, and territorial public health jurisdiction, BioSense 2.0
provides a second secure space in the cloud for public health
jurisdictions to share aggregate data with other participating
jurisdictions and CDC. Whenever possible, the BioSense
[[Page 33465]]
Program plans to share aggregate-level pharmacy and laboratory data
with public health jurisdictions. To participate in the shared space,
jurisdiction administrators must simply select from drop-down lists to
choose their sharing permissions on the BioSense 2.0 application, and
they will have the right at any time to revise the level of sharing
permissions regarding the data in their secure space.
As part of access to the shared space, public health jurisdictions
will be required to grant CDC access to, at minimum, aggregate level
data (city, county, or state) from their jurisdiction that has been
placed in the shared space. They must also agree that CDC may review
data contributed to the shared space for public health practice and
surveillance purposes.
In order to continue meeting the congressional mandate in the
BioSense 2.0 application, the BioSense Program maintains 3 different
types of information collection: (1) Contact information (name,
telephone number, email address, and street address) needed for
recruitment of up to 20 participating public health jurisdictions to
BioSense 2.0 per year; (2) one-time collection of information (name,
email address, title, organizational affiliation, security questions,
and password) to provide access to the BioSense 2.0 cloud and its tools
for all appropriate users in participating jurisdictions and
organizations, and (3) collection of already existing healthcare
encounter data submitted to the cloud via electronic record
transmission from participating public health jurisdictions' non-
federal hospitals, VA, DoD, two national-level private sector clinical
laboratories, and a private sector health information exchange firm.
Though a large number of electronic records are transmitted from each
entity each year, once the automated interfaces are set up for
transmission (choosing sharing permissions), there is no human burden
for record transmission.
This request is for a 3-year approval. There are no costs to survey
respondents other than their time to participate.
Estimates of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Recruitment
----------------------------------------------------------------------------------------------------------------
State, Local, and Territorial Public Health 20 1 1 20
Jurisdictions..................................
Federal Government.............................. 2 1 1 2
Private Sector (national clinical laboratory 3 1 1 3
corporations, and a private sector health
information exchange company)..................
----------------------------------------------------------------------------------------------------------------
Access to BioSense 2.0 Application
----------------------------------------------------------------------------------------------------------------
State, Local, and Territorial Public Health 200 1 5/60 17
Jurisdictions..................................
Federal Government.............................. 30 1 5/60 3
Private Sector.................................. 50 1 5/60 4
----------------------------------------------------------------------------------------------------------------
Data Collection: Administrator Sharing Permissions
----------------------------------------------------------------------------------------------------------------
State, Local, and Territorial Public Health 20 1 5/60 2
Jurisdictions..................................
Federal Government.............................. 2 0 0 0
Private Sector (national clinical laboratory 3 0 0 0
corporations, and a private sector health
information exchange company)..................
---------------------------------------------------------------
Total....................................... .............. .............. .............. 51
----------------------------------------------------------------------------------------------------------------
Kimberly S. Lane,
Deputy Director, Office of Science Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012-13689 Filed 6-5-12; 8:45 am]
BILLING CODE 4163-18-P
